Larsen and Toubro (Rs 1161.5): Larsen and Toubro has long-term resistance in the zone between Rs 2200 and Rs 2400. It peaked in this zone in November 2007 and again in November 2010.

Pharma major Lupin launched an anti-HIV drug Combivir Generic, which is expected to be a limited competition drug for the company.

Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

FARMERS are becoming increasingly convinced they are flogging a dead horse when it comes to growing lupins. While lupins are undisputedly the perfect crop to increase profitably in a cereal rotation, farmers this year are discarding them or reducing ...

Lupin sales growth for Q4FY12 was better than our expectation but net profit growth was below our expectation due to lower than expected margin and higher tax provision.